Why the study?
Does serial gadolinium-enhanced MRI show differences in new lesions and enhancement between early relapsing/remitting MS and benign MS?
Population
Patients with early relapsing/remitting multiple sclerosis (MS) and benign MS
Design
Cohort
Authors
Loading...
Serial gadolinium-enhanced MRI demonstrates differences in lesion production and enhancement between early relapsing/remitting and benign MS, suggesting clinical subtype should guide MRI monitoring protocols.
Does serial gadolinium-enhanced MRI show differences in new lesions and enhancement between early relapsing/remitting MS and benign MS?
Serial gadolinium-enhanced MRI demonstrates differences in lesion production and enhancement between early relapsing/remitting and benign MS, suggesting clinical subtype should guide MRI monitoring protocols.
Thompson et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: